RESTYLANE INJECTION GEL
FDA premarket approval P040024/S001 · decided 2005-07-12
Approval details
- PMA number
- P040024
- Supplement
- S001
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- RESTYLANE INJECTION GEL
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2005-06-16
- Decision date
- 2005-07-12
- Days to decision
- 26 days
- Decision code
- OK30
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- CHANGES TO PROCESSING METHODS USED IN THE MANUFACTURING OF RESTYLANE INJECTABLE GEL.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.